Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free
Close

Sino Biopharmaceutical Ltd (1177)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.54 +0.04    +0.89%
08:08:05 - Closed. Currency in HKD ( Disclaimer )
  • Volume: 42,690,214
  • Bid/Ask: 4.54 / 4.55
  • Day's Range: 4.46 - 4.59
Type:  Equity
Market:  Hong Kong
ISIN:  KYG8167W1380 
Sino Biopharmaceutical 4.54 +0.04 +0.89%

1177 Income Statement

 
Assess the Sino Biopharmaceutical Ltd income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2022
30/06
2022
31/03
2021
31/12
2021
30/09
Total Revenue 7596.87 7596.87 - 6253.79
Revenue 7596.87 7596.87 - 6253.79
Other Revenue, Total - - - -
Cost of Revenue, Total 1479.8 1479.8 - 1289.49
Gross Profit 6117.07 6117.07 - 4964.3
Total Operating Expenses 6016.14 6016.14 - 5705.09
Selling/General/Admin. Expenses, Total 3466.95 3466.95 - 3010.84
Research & Development 1024.3 1024.3 - 982.74
Depreciation / Amortization - - - -
Interest Expense (Income) - Net Operating -84.64 -84.64 - -80.7
Unusual Expense (Income) - - -3.73 -
Other Operating Expenses, Total 129.72 129.72 - 502.72
Operating Income 1580.73 1580.73 - 548.69
Interest Income (Expense), Net Non-Operating - - 13322.17 -
Gain (Loss) on Sale of Assets -57.13 -57.13 - -20
Other, Net -239.44 -239.44 - -3228.39
Net Income Before Taxes 1877.31 1877.31 - 3797.08
Provision for Income Taxes 285.7 285.7 - 310.48
Net Income After Taxes 1591.61 1591.61 - 3486.59
Minority Interest 8530.46 8530.46 7437.91 7437.91
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 960.52 960.52 - 3064.04
Total Extraordinary Items - - - -
Net Income 960.52 960.52 - 3064.04
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 960.52 960.52 - 3064.04
Dilution Adjustment 80.47 80.47 - 184.99
Diluted Net Income 880.05 880.05 - 2879.05
Diluted Weighted Average Shares 19122.74 19122.74 - 19276.91
Diluted EPS Excluding Extraordinary Items 0.046 0.046 - 0.149
DPS - Common Stock Primary Issue 0.026 0.026 - 0.016
Diluted Normalized EPS 0.03 0.03 - 0.103
* In Millions of CNY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

1177 Comments

Write your thoughts about Sino Biopharmaceutical Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email